Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Denmark Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20071
20081
20094
20101
20132
20153
20161
20172
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
Rigshospitalet, Denmark2
Amgen1
Bayer1
Bristol-Myers Squibb1
GlaxoSmithKline1
Herlev Hospital1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung24
Lung Neoplasms6
Melanoma2
Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma1
Colorectal Neoplasms1
Mesothelioma1
Mesothelioma, Malignant1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.